Luke Miels's most recent trade in GSK Plc - ADR was a trade of 664 Ords 0.31p done at an average price of $19.6 . Disclosure was reported to the exchange on July 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.59 per share. | 10 Jul 2026 | 664 | 1,482,285 (0%) | 0% | 19.6 | 13,011 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.59 per share. | 10 Jul 2026 | 333 | 1,482,618 (0%) | 0% | 19.6 | 6,525 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.59 per share. | 10 Jul 2026 | 244 | 1,482,862 (0%) | 0% | 19.6 | 4,781 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.62 per share. | 09 Jul 2026 | 21 | 1,481,621 (0%) | 0% | 19.6 | 412 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 19.67 per share. | 09 Jul 2026 | 3 | 1,481,600 (0%) | 0% | 19.7 | 59 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.67 per share. | 14 Apr 2026 | 630 | 1,481,281 (0%) | 0% | 21.7 | 13,652 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.67 per share. | 14 Apr 2026 | 316 | 1,481,597 (0%) | 0% | 21.7 | 6,848 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.67 per share. | 14 Apr 2026 | 232 | 1,480,651 (0%) | 0% | 21.7 | 5,027 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.50 per share. | 09 Apr 2026 | 2,393 | 1,480,419 (0%) | 0% | 21.5 | 51,459 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 21.50 per share. | 09 Apr 2026 | 2 | 1,478,026 (0%) | 0% | 21.5 | 43 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | 13 Feb 2026 | 245,716 | 326,483 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.60 per share. | 13 Feb 2026 | 15,579 | 310,904 (0%) | 0% | 21.6 | 336,510 | Ords 0.31p |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | 10 Feb 2026 | 24,979 | 80,767 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | 09 Feb 2026 | 60,334 | 60,337 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | 09 Feb 2026 | 4,549 | 55,788 (0%) | 0% | 22.1 | 100,597 | Ords 0.31p | |
| GSK PLC (ADR) | Luke Miels | Executive Director,Chief Executive Officer | Sale or transfer of securities back to the company at price $ 19.00 per share. | 08 Jan 2026 | 3 | 3 (0%) | 0% | 19 | 57 | Ords 0.31p |